1. Home
  2. CTSO vs GMM Comparison

CTSO vs GMM Comparison

Compare CTSO & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.72

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

HOLD

Current Price

$1.28

Market Cap

38.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
GMM
Founded
1997
2017
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
38.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CTSO
GMM
Price
$0.72
$1.28
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
126.1K
15.8K
Earning Date
11-13-2025
08-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.79
Revenue
$36,979,520.00
$48,171,048.00
Revenue This Year
$9.51
N/A
Revenue Next Year
$24.40
N/A
P/E Ratio
N/A
$0.71
Revenue Growth
23.89
41.74
52 Week Low
$0.60
$1.23
52 Week High
$1.61
$4.97

Technical Indicators

Market Signals
Indicator
CTSO
GMM
Relative Strength Index (RSI) 46.64 30.01
Support Level $0.70 $1.25
Resistance Level $0.85 $1.59
Average True Range (ATR) 0.07 0.09
MACD 0.01 -0.02
Stochastic Oscillator 52.04 28.21

Price Performance

Historical Comparison
CTSO
GMM

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: